Atlas Trials

The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)

Clinical trial NCT02407821 · TERMINATED

Trial details

NCT number
NCT02407821
Sponsor
University Health Network, Toronto
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
End Stage Renal Disease
Start date
2015-03-01
Primary completion
2017-01-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.